{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:53:50Z","timestamp":1786377230680,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier","isbn-type":[{"value":"9780128178744","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.pmbts.2019.06.001","type":"book-chapter","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T07:03:44Z","timestamp":1561532624000},"page":"205-217","source":"Crossref","is-referenced-by-count":19,"title":["Alzheimer's therapy development: A few points to consider"],"prefix":"10.1016","author":[{"given":"Einar M.","family":"Sigurdsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pmbts.2019.06.001_bb0010","doi-asserted-by":"crossref","first-page":"S555","DOI":"10.3233\/JAD-179937","article-title":"Tau immunotherapies for Alzheimer's disease and related tauopathies: progress and potential pitfalls","volume":"64","author":"Sigurdsson","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0020","first-page":"44","article-title":"A quantitative analysis of brain soluble tau and the tau secretion factor","volume":"76","author":"Han","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0025","doi-asserted-by":"crossref","first-page":"13110","DOI":"10.1523\/JNEUROSCI.2569-11.2011","article-title":"In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice","volume":"31","author":"Yamada","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2012.05.021","article-title":"Constitutive secretion of tau protein by an unconventional mechanism","volume":"48","author":"Chai","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0035","doi-asserted-by":"crossref","first-page":"33081","DOI":"10.1074\/jbc.M113.494922","article-title":"Two novel tau antibodies targeting the 396\/404 region are primarily taken up by neurons and reduce tau protein pathology","volume":"288","author":"Gu","year":"2013","journal-title":"J Biol Chem."},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0040","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1073\/pnas.1607215114","article-title":"Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation","volume":"114","author":"McEwan","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0045","author":"ClinicalTrials gov"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0050","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1023\/B:NEUR.0000021904.61387.95","article-title":"Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau","volume":"32","author":"Lin","year":"2003","journal-title":"J Neurocytol"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2019.03.033","article-title":"Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy","volume":"42","author":"Congdon","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0060","doi-asserted-by":"crossref","first-page":"35452","DOI":"10.1074\/jbc.M113.491001","article-title":"Antibody uptake into neurons occurs primarily via clathrin-dependent fcgamma receptor endocytosis and is a prerequisite for acute tau protein clearance","volume":"288","author":"Congdon","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-016-0126-z","article-title":"Affinity of tau antibodies for solubilized pathological tau species but not their immunogen or insoluble tau aggregates predicts in vivo and ex vivo efficacy","volume":"11","author":"Congdon","year":"2016","journal-title":"Mol Neurodegener"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ebiom.2018.08.041","article-title":"Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging","volume":"35","author":"Wu","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1471-4914(02)02403-6","article-title":"Infectivity of amyloid diseases","volume":"8","author":"Sigurdsson","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11910-014-0495-z","article-title":"Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies","volume":"14","author":"Goedert","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamaneurol.2013.1453","article-title":"Mechanisms of protein seeding in neurodegenerative diseases","volume":"70","author":"Walker","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0090","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature09768","article-title":"Prion propagation and toxicity in vivo occur in two distinct mechanistic phases","volume":"470","author":"Sandberg","year":"2011","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/mp.2017.84","article-title":"Treatment with a non-toxic, self-replicating anti-prion delays or prevents prion disease in vivo","volume":"23","author":"Diaz-Espinoza","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0100","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","article-title":"Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo","volume":"92","author":"Kaufman","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0105","doi-asserted-by":"crossref","first-page":"e37813","DOI":"10.7554\/eLife.37813","article-title":"Tau monomer encodes strains","volume":"7","author":"Sharma","year":"2018","journal-title":"Elife"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0110","unstructured":"Alzforum Therapeutics Database, https:\/\/www.alzforum.org\/therapeutics\/search?fda_statuses=&target_types%5B%5D=170&therapy_types=&conditions=&keywords-entry=&keywords=#results. Accessed 05\/08\/19 2019."},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0115","doi-asserted-by":"crossref","first-page":"10598","DOI":"10.1523\/JNEUROSCI.2990-05.2005","article-title":"Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain","volume":"25","author":"Klunk","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","author":"Leuzy","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer's disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","article-title":"Structures of filaments from Pick's disease reveal a novel tau protein fold","volume":"561","author":"Falcon","year":"2018","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0135","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1126\/science.1173155","article-title":"Functional amyloids as natural storage of peptide hormones in pituitary secretory granules","volume":"325","author":"Maji","year":"2009","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2019.06.001_bb0140","doi-asserted-by":"crossref","first-page":"16835","DOI":"10.1523\/JNEUROSCI.2755-14.2014","article-title":"Antibody-derived in vivo imaging of tau pathology","volume":"34","author":"Krishnaswamy","year":"2014","journal-title":"J Neurosci"}],"container-title":["Progress in Molecular Biology and Translational Science","Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117319300912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117319300912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T20:32:28Z","timestamp":1572899548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117319300912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128178744"],"references-count":27,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2019.06.001","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}